Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 19, 2024 1:38 PM 2 min read

Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services

by Vandana Singh Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

According to a report, U.S. healthcare spending grew by 7.5% to $4.9 trillion in 2023. The increase was fueled by higher enrollment in private health plans and expanded use of medical services, driven by legislative changes and post-pandemic rebounds in care utilization.

Healthcare spending accounted for 17.6% of the U.S. economy, outpacing GDP growth of 2.9%. Spending on retail prescription drugs saw the most significant rise, jumping 11.4% to $449.7 billion.

The report attributed this to increased use of medications for obesity and diabetes.

Also Read: Donald Trump’s Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare

The rapid growth in spending for drugs used to treat diabetes and obesity contributed to faster overall growth in retail prescription drug expenditures and private health insurance and Medicare spending growth.

Hospital care spending rose 10.4% to $1.5 trillion in 2023, marking the fastest growth since 1990. Hospital discharges increased by 1.6%, with Medicare beneficiaries driving higher outpatient service utilization.

Spending on physician and clinical services also climbed by 7.4% to $978 billion, with private insurance and Medicare patients contributing to this rise.

Enrollment in private health insurance grew by 1.6%, adding 3.3 million Americans.

Private insurance spending surged by 11.5%, reaching $1.5 trillion and accounting for 30% of national healthcare expenditures.

Medicare spending grew 8.1% to $1 trillion, representing 21% of total healthcare spending. Medicaid spending, however, grew more slowly at 7.9%, reflecting the end of the COVID-19 public health emergency.

The report also revealed that 92.5% of Americans had health insurance in 2023, up from 92.0% in 2022, underscoring the broader coverage expansion in recent years.

Read Next:

  • Amazon Has 20,000 Rivian Electric Delivery Vans In Fleet: Here’s What Could Be Next For Both Companies

Photo by MargJohnsonVA via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
BiotechGovernmentNewsHealth CareTop StoriesGeneralBriefsStories That Matter
BMY Logo
BMYBristol-Myers Squibb Co
$61.75-0.39%
Overview
CI Logo
CIThe Cigna Group
$291.82-0.08%
CNC Logo
CNCCentene Corp
$38.45-0.03%
CVS Logo
CVSCVS Health Corp
$78.20-0.19%
DGX Logo
DGXQuest Diagnostics Inc
$188.58-1.12%
ELV Logo
ELVElevance Health Inc
$338.98-%
GSK Logo
GSKGSK PLC
$60.03-0.33%
HQY Logo
HQYHealthEquity Inc
$79.45-%
HUM Logo
HUMHumana Inc
$194.600.34%
IHE Logo
IHEiShares U.S. Pharmaceutical ETF
$90.362.33%
IHF Logo
IHFiShares U.S. Health Care Providers ETF
$45.090.90%
IYH Logo
IYHiShares U.S. Healthcare ETF
$65.861.82%
JNJ Logo
JNJJohnson & Johnson
$239.88-0.05%
LLY Logo
LLYEli Lilly and Co
$1068.000.93%
MRK Logo
MRKMerck & Co Inc
$121.56-0.30%
NVO Logo
NVONovo Nordisk AS
$49.944.83%
NVS Logo
NVSNovartis AG
$153.95-1.58%
PFE Logo
PFEPfizer Inc
$27.16-0.22%
UNH Logo
UNHUnitedHealth Group Inc
$276.10-0.20%
VHT Logo
VHTVanguard Health Care ETF
Not Available-%
BMY Logo
BMYBristol-Myers Squibb Co
$61.75-0.39%
Overview
CI Logo
CIThe Cigna Group
$291.82-0.08%
CNC Logo
CNCCentene Corp
$38.45-0.03%
CVS Logo
CVSCVS Health Corp
$78.20-0.19%
DGX Logo
DGXQuest Diagnostics Inc
$188.58-1.12%
ELV Logo
ELVElevance Health Inc
$338.98-%
GSK Logo
GSKGSK PLC
$60.03-0.33%
HQY Logo
HQYHealthEquity Inc
$79.45-%
HUM Logo
HUMHumana Inc
$194.600.34%
IHE Logo
IHEiShares U.S. Pharmaceutical ETF
$90.362.33%
IHF Logo
IHFiShares U.S. Health Care Providers ETF
$45.090.90%
IYH Logo
IYHiShares U.S. Healthcare ETF
$65.861.82%
JNJ Logo
JNJJohnson & Johnson
$239.88-0.05%
LLY Logo
LLYEli Lilly and Co
$1068.000.93%
MRK Logo
MRKMerck & Co Inc
$121.56-0.30%
NVO Logo
NVONovo Nordisk AS
$49.944.83%
NVS Logo
NVSNovartis AG
$153.95-1.58%
PFE Logo
PFEPfizer Inc
$27.16-0.22%
UNH Logo
UNHUnitedHealth Group Inc
$276.10-0.20%
VHT Logo
VHTVanguard Health Care ETF
Not Available-%
Comments
Loading...